JRAD Awarded $249M Army CBRND Contract

STAFFORD, VA., OCT 3, 2018 – JRAD was recently awarded a U.S. Army contract supporting the Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense (JPEO-CBRND) with a ceiling value of $249M.

The contract was competitively awarded as part of the Joint Enterprise – Omnibus Program, Engineering and Technical Support (JE-OPETS) Acquisition (ACQ) program to support the JPEO-CBRND, including its Headquarters, Directorates and five Joint Project Managers (JPMs). The JPEO-CBRND manages a diverse portfolio of critical warfighting capabilities requiring an approach for cohesive and innovative total life cycle systems management to rapidly respond to customer needs in a cost-effective manner. This contract will facilitate the JPEO-CBRND in meeting the schedule-drive, critical solutions of the Warfighter across the JPEO-CBRND Enterprise.

Mr. Mike Diederen, JRAD’s President, said, “We are very excited and privileged to be given an opportunity to support the JPEO-CBRND through our award of JE-OPETS ACQ. This will allow us to continue the relationship with our core clients whom we have been supporting since our inception in 2004.”

About JRAD
Founded in 2004, Joint Research and Development, Inc. (JRAD) has been providing exceptional service in core focus areas of decision analysis, test and evaluation and science and technology to Federal clients. Their strength is in fusing the links of all facets of the acquisition lifecycle, including the aforementioned core focus areas, to enable clients to make defensible decisions. Having no laboratory or manufacturing affiliations, they provide impartial and objective assessments and assist in transforming client objectives into client achievements through innovative ideas, reliable expertise and unbiased advice.